Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.

O'Shea D, Law J, Egli A, Douglas D, Lund G, Forester S, Lambert J, Law M, Burton DR, Tyrrell DL, Houghton M, Humar A, Kneteman N

Open source

DOI: 10.1002/lt.24344
Published: 2016 Mar
Container: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/lt.24344,
  title = {Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.},
  author = {O'Shea D and Law J and Egli A and Douglas D and Lund G and Forester S and Lambert J and Law M and Burton DR and Tyrrell DL and Houghton M and Humar A and Kneteman N},
  year = {2016},
  journal = {Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society},
  doi = {10.1002/lt.24344},
  url = {https://doi.org/10.1002/lt.24344}
}

RIS

TY  - JOUR
TI  - Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.
AU  - O'Shea D
AU  - Law J
AU  - Egli A
AU  - Douglas D
AU  - Lund G
AU  - Forester S
AU  - Lambert J
AU  - Law M
AU  - Burton DR
AU  - Tyrrell DL
AU  - Houghton M
AU  - Humar A
AU  - Kneteman N
PY  - 2016
JO  - Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
DO  - 10.1002/lt.24344
UR  - https://doi.org/10.1002/lt.24344
ER  -

APA

D, O., J, L., A, E., D, D., G, L., S, F., J, L., M, L., DR, B., DL, T., M, H., A, H., & N, K. (2016). Prevention of hepatitis C virus infection using a broad cross-neutralizing monoclonal antibody (AR4A) and epigallocatechin gallate.. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. https://doi.org/10.1002/lt.24344

Source records

pubmed · retrieved 2026-09-26T12:24:49.200Z